The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pre-Exposure Prophylaxis Market Research Report 2025
Synopsis
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
The global Pre-Exposure Prophylaxis market was valued at US$ 233 million in 2023 and is anticipated to reach US$ 327 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pre-Exposure Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Exposure Prophylaxis.
Report Scope
The Pre-Exposure Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pre-Exposure Prophylaxis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pre-Exposure Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Segment by Type
Truvada
Discovy
Segment by Application
Adult
Adolescent
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pre-Exposure Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
The global Pre-Exposure Prophylaxis market was valued at US$ 233 million in 2023 and is anticipated to reach US$ 327 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pre-Exposure Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Exposure Prophylaxis.
Report Scope
The Pre-Exposure Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pre-Exposure Prophylaxis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pre-Exposure Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Segment by Type
Truvada
Discovy
Segment by Application
Adult
Adolescent
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pre-Exposure Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pre-Exposure Prophylaxis Market Overview
1.1 Product Overview and Scope of Pre-Exposure Prophylaxis
1.2 Pre-Exposure Prophylaxis Segment by Type
1.2.1 Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2024-2030)
1.2.2 Truvada
1.2.3 Discovy
1.3 Pre-Exposure Prophylaxis Segment by Application
1.3.1 Global Pre-Exposure Prophylaxis Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Adolescent
1.4 Global Pre-Exposure Prophylaxis Market Size Estimates and Forecasts
1.4.1 Global Pre-Exposure Prophylaxis Revenue 2019-2030
1.4.2 Global Pre-Exposure Prophylaxis Sales 2019-2030
1.4.3 Global Pre-Exposure Prophylaxis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pre-Exposure Prophylaxis Market Competition by Manufacturers
2.1 Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pre-Exposure Prophylaxis Average Price by Manufacturers (2019-2024)
2.4 Global Pre-Exposure Prophylaxis Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Type & Application
2.7 Pre-Exposure Prophylaxis Market Competitive Situation and Trends
2.7.1 Pre-Exposure Prophylaxis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pre-Exposure Prophylaxis Players Market Share by Revenue
2.7.3 Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pre-Exposure Prophylaxis Retrospective Market Scenario by Region
3.1 Global Pre-Exposure Prophylaxis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pre-Exposure Prophylaxis Global Pre-Exposure Prophylaxis Sales by Region: 2019-2030
3.2.1 Global Pre-Exposure Prophylaxis Sales by Region: 2019-2024
3.2.2 Global Pre-Exposure Prophylaxis Sales by Region: 2025-2030
3.3 Global Pre-Exposure Prophylaxis Global Pre-Exposure Prophylaxis Revenue by Region: 2019-2030
3.3.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2019-2024
3.3.2 Global Pre-Exposure Prophylaxis Revenue by Region: 2025-2030
3.4 North America Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.4.1 North America Pre-Exposure Prophylaxis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pre-Exposure Prophylaxis Sales by Country (2019-2030)
3.4.3 North America Pre-Exposure Prophylaxis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.5.1 Europe Pre-Exposure Prophylaxis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pre-Exposure Prophylaxis Sales by Country (2019-2030)
3.5.3 Europe Pre-Exposure Prophylaxis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.6.1 Asia Pacific Pre-Exposure Prophylaxis Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pre-Exposure Prophylaxis Sales by Country (2019-2030)
3.6.3 Asia Pacific Pre-Exposure Prophylaxis Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.7.1 Latin America Pre-Exposure Prophylaxis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pre-Exposure Prophylaxis Sales by Country (2019-2030)
3.7.3 Latin America Pre-Exposure Prophylaxis Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pre-Exposure Prophylaxis Market Facts & Figures by Country
3.8.1 Middle East and Africa Pre-Exposure Prophylaxis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pre-Exposure Prophylaxis Sales by Type (2019-2030)
4.1.1 Global Pre-Exposure Prophylaxis Sales by Type (2019-2024)
4.1.2 Global Pre-Exposure Prophylaxis Sales by Type (2025-2030)
4.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2019-2030)
4.2 Global Pre-Exposure Prophylaxis Revenue by Type (2019-2030)
4.2.1 Global Pre-Exposure Prophylaxis Revenue by Type (2019-2024)
4.2.2 Global Pre-Exposure Prophylaxis Revenue by Type (2025-2030)
4.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2019-2030)
4.3 Global Pre-Exposure Prophylaxis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pre-Exposure Prophylaxis Sales by Application (2019-2030)
5.1.1 Global Pre-Exposure Prophylaxis Sales by Application (2019-2024)
5.1.2 Global Pre-Exposure Prophylaxis Sales by Application (2025-2030)
5.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2019-2030)
5.2 Global Pre-Exposure Prophylaxis Revenue by Application (2019-2030)
5.2.1 Global Pre-Exposure Prophylaxis Revenue by Application (2019-2024)
5.2.2 Global Pre-Exposure Prophylaxis Revenue by Application (2025-2030)
5.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2019-2030)
5.3 Global Pre-Exposure Prophylaxis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Strides Pharma Science
6.3.1 Strides Pharma Science Corporation Information
6.3.2 Strides Pharma Science Description and Business Overview
6.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio
6.3.5 Strides Pharma Science Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Corporation Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Pre-Exposure Prophylaxis Product Portfolio
6.4.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pre-Exposure Prophylaxis Industry Chain Analysis
7.2 Pre-Exposure Prophylaxis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pre-Exposure Prophylaxis Production Mode & Process
7.4 Pre-Exposure Prophylaxis Sales and Marketing
7.4.1 Pre-Exposure Prophylaxis Sales Channels
7.4.2 Pre-Exposure Prophylaxis Distributors
7.5 Pre-Exposure Prophylaxis Customers
8 Pre-Exposure Prophylaxis Market Dynamics
8.1 Pre-Exposure Prophylaxis Industry Trends
8.2 Pre-Exposure Prophylaxis Market Drivers
8.3 Pre-Exposure Prophylaxis Market Challenges
8.4 Pre-Exposure Prophylaxis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pre-Exposure Prophylaxis Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pre-Exposure Prophylaxis Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pre-Exposure Prophylaxis Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pre-Exposure Prophylaxis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Type & Application
Table 12. Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pre-Exposure Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Exposure Prophylaxis as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pre-Exposure Prophylaxis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pre-Exposure Prophylaxis Sales by Region (2019-2024) & (K Units)
Table 18. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2019-2024)
Table 19. Global Pre-Exposure Prophylaxis Sales by Region (2025-2030) & (K Units)
Table 20. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2025-2030)
Table 21. Global Pre-Exposure Prophylaxis Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2019-2024)
Table 23. Global Pre-Exposure Prophylaxis Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2025-2030)
Table 25. North America Pre-Exposure Prophylaxis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pre-Exposure Prophylaxis Sales by Country (2019-2024) & (K Units)
Table 27. North America Pre-Exposure Prophylaxis Sales by Country (2025-2030) & (K Units)
Table 28. North America Pre-Exposure Prophylaxis Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pre-Exposure Prophylaxis Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pre-Exposure Prophylaxis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pre-Exposure Prophylaxis Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pre-Exposure Prophylaxis Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pre-Exposure Prophylaxis Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pre-Exposure Prophylaxis Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pre-Exposure Prophylaxis Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pre-Exposure Prophylaxis Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pre-Exposure Prophylaxis Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pre-Exposure Prophylaxis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pre-Exposure Prophylaxis Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pre-Exposure Prophylaxis Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pre-Exposure Prophylaxis Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pre-Exposure Prophylaxis Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pre-Exposure Prophylaxis Sales (K Units) by Type (2019-2024)
Table 51. Global Pre-Exposure Prophylaxis Sales (K Units) by Type (2025-2030)
Table 52. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2019-2024)
Table 53. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2025-2030)
Table 54. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2019-2024)
Table 57. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2025-2030)
Table 58. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pre-Exposure Prophylaxis Sales (K Units) by Application (2019-2024)
Table 61. Global Pre-Exposure Prophylaxis Sales (K Units) by Application (2025-2030)
Table 62. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2019-2024)
Table 63. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2025-2030)
Table 64. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pre-Exposure Prophylaxis Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2019-2024)
Table 67. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2025-2030)
Table 68. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2025-2030)
Table 70. Gilead Sciences Corporation Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Gilead Sciences Pre-Exposure Prophylaxis Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Strides Pharma Science Corporation Information
Table 81. Strides Pharma Science Description and Business Overview
Table 82. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Strides Pharma Science Pre-Exposure Prophylaxis Product
Table 84. Strides Pharma Science Recent Developments/Updates
Table 85. Lupin Corporation Information
Table 86. Lupin Description and Business Overview
Table 87. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Lupin Pre-Exposure Prophylaxis Product
Table 89. Lupin Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Pre-Exposure Prophylaxis Distributors List
Table 93. Pre-Exposure Prophylaxis Customers List
Table 94. Pre-Exposure Prophylaxis Market Trends
Table 95. Pre-Exposure Prophylaxis Market Drivers
Table 96. Pre-Exposure Prophylaxis Market Challenges
Table 97. Pre-Exposure Prophylaxis Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pre-Exposure Prophylaxis
Figure 2. Global Pre-Exposure Prophylaxis Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pre-Exposure Prophylaxis Market Share by Type in 2023 & 2030
Figure 4. Truvada Product Picture
Figure 5. Discovy Product Picture
Figure 6. Global Pre-Exposure Prophylaxis Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pre-Exposure Prophylaxis Market Share by Application in 2023 & 2030
Figure 8. Adult
Figure 9. Adolescent
Figure 10. Global Pre-Exposure Prophylaxis Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pre-Exposure Prophylaxis Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pre-Exposure Prophylaxis Sales (2019-2030) & (K Units)
Figure 13. Global Pre-Exposure Prophylaxis Average Price (US$/Unit) & (2019-2030)
Figure 14. Pre-Exposure Prophylaxis Report Years Considered
Figure 15. Pre-Exposure Prophylaxis Sales Share by Manufacturers in 2023
Figure 16. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pre-Exposure Prophylaxis Players: Market Share by Revenue in 2023
Figure 18. Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pre-Exposure Prophylaxis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pre-Exposure Prophylaxis Sales Market Share by Country (2019-2030)
Figure 21. North America Pre-Exposure Prophylaxis Revenue Market Share by Country (2019-2030)
Figure 22. United States Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2019-2030)
Figure 25. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pre-Exposure Prophylaxis Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pre-Exposure Prophylaxis Revenue Market Share by Region (2019-2030)
Figure 33. China Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Pre-Exposure Prophylaxis Sales Market Share by Country (2019-2030)
Figure 43. Latin America Pre-Exposure Prophylaxis Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Pre-Exposure Prophylaxis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Pre-Exposure Prophylaxis by Type (2019-2030)
Figure 53. Global Revenue Market Share of Pre-Exposure Prophylaxis by Type (2019-2030)
Figure 54. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Pre-Exposure Prophylaxis by Application (2019-2030)
Figure 56. Global Revenue Market Share of Pre-Exposure Prophylaxis by Application (2019-2030)
Figure 57. Global Pre-Exposure Prophylaxis Price (US$/Unit) by Application (2019-2030)
Figure 58. Pre-Exposure Prophylaxis Value Chain
Figure 59. Pre-Exposure Prophylaxis Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
